Open tender · Germany · Contract notice
Open house Arzneimittelrabattverträge Dornase alfa (Desoxyribonuclease), ATC R05CB13
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge Dornase alfa (Desoxyribonuclease), ATC R05CB13”. Bids close on 3 August 2027.
The work
Non-exclusive discount agreements for the drug Dornase alfa (Desoxyribonuclease), ATC R05CB13.
- Identical and non-negotiable discount agreements
- Contract end date is 30.09.2027
- One-month notice for cancellation at month-end
Key facts
- Contract period
- 01.10.2025 to 30.09.2027
- Evaluation
- Not a selection procedure, but a contract offer to all eligible companies.
- Price basis
- non-individually negotiable discount agreements
What it takes to qualify
Worth a closer look
- The document is in German and describes an 'open-house' model, not a standard tender. The term 'pharmazeutische Unternehmen' is used, which is a specific type of entity.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- ausgefüllte und unterzeichnete Eigenerklärung zur Zuverlässigkeitdownloadable from tender documents
- ausgefüllter und unterzeichneter Vertragrequires proof of representation from trade register or power of attorney
- ausgefüllte und unterzeichnete Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"part of contract submission
- Handunterschrift in 2-facher Fassung im Originalphysical submission to AOK Bayern address
- elektronische Unterlagen mit qualifizierter elektronischer Signatursubmission via dtvp.de communication area